SUBSCRIBE
SUBSCRIBE

AstraZeneca

NEWS
Genetown
1 In 5 Early-Stage Breast Cancer Patients May Not Follow Hormonal Therapy Plan
December 18, 2006
 · 
1 min read
Policy
Out Of REACH: New Legislation Threatens Medicines
November 20, 2006
 · 
1 min read
Genetown
The Day In Review: Cambrex Corporation Sells Bio Businesses For $460 Million
October 24, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Synta Pharmaceuticals Reports Progress Against Melanoma
September 15, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Ligand Pharmaceuticals Inc. Sells Avinza To King Pharmaceuticals®, Inc. For $265 Million
September 7, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
 · 
1 min read
Business
The Day In Review: Biogen Idec, Inc. (Massachusetts) Invests In ALS Compound
August 4, 2006
 · 
1 min read
Drug Development
The Day In Review: Pozen, Inc. Inks Pain Deal With AstraZeneca PLC
August 3, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Crucell N.V. And Astellas Pharma Inc. Abandon Drugs
July 18, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
May 1, 2026
 · 
15 min read
Press Releases
Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca
April 29, 2026
 · 
3 min read
Press Releases
AstraZeneca results: Q1 2026
April 29, 2026
 · 
8 min read
Press Releases
BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
April 28, 2026
 · 
12 min read
Press Releases
SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
April 27, 2026
 · 
16 min read
Press Releases
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
April 20, 2026
 · 
6 min read
Press Releases
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
April 20, 2026
 · 
10 min read
Press Releases
Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus
April 14, 2026
 · 
9 min read
Press Releases
IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer
April 2, 2026
 · 
19 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
March 9, 2026
 · 
19 min read
Load More